Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-19 9:44 pm Sale | 2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,770,792 4.100% | -1,684,184 (-48.75%) | Filing History |
2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 3,951,287 9.990% | 3,951,287 (New Position) | Filing History |
2024-11-14 4:30 pm Purchase | 2024-08-07 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 3,454,976 8.800% | 380,434 (+12.37%) | Filing History |
2024-11-14 12:51 pm Sale | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 4,081,099 10.500% | -82,579 (-1.98%) | Filing History |
2024-11-14 09:36 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Avoro Capital Advisors LLC | 2,181,000 5.600% | 2,181,000 (New Position) | Filing History |
2024-11-12 09:33 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management L.P. | 3,322,146 8.550% | 3,322,146 (New Position) | Filing History |
2024-10-24 4:44 pm Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | BlackRock Inc. BLK | 2,011,817 5.200% | 2,011,817 (New Position) | Filing History |
2024-10-21 4:31 pm Sale | 2024-10-17 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,003,101 4.990% | -464,998 (-18.84%) | Filing History |
2024-10-15 4:31 pm Sale | 2024-10-10 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,468,099 6.200% | -782,979 (-24.08%) | Filing History |
2024-10-10 4:30 pm Sale | 2024-10-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,251,078 8.100% | -745,287 (-18.65%) | Filing History |
2024-10-03 09:55 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 4,163,678 10.100% | 1,639,781 (+64.97%) | Filing History |
2024-09-10 6:30 pm Purchase | 2024-09-06 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 3,996,365 9.990% | 1,102,750 (+38.11%) | Filing History |
2024-09-05 6:37 pm Sale | 2024-08-27 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 6,291,851 16.200% | -1,025,000 (-14.01%) | Filing History |
2024-05-01 1:07 pm Sale | 2024-04-29 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings L.P. | 7,316,851 22.500% | -1,101,242 (-13.08%) | Filing History |
2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 3,068,031 9.900% | 2,229,497 (+265.88%) | Filing History |
2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | COMMODORE CAPITAL LP | 700,000 2.300% | -185,741 (-20.97%) | Filing History |
2024-02-13 5:35 pm Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 2,523,897 8.300% | 1,064,197 (+72.91%) | Filing History |
2024-02-07 08:01 am Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP LLC | 1,826,814 5.990% | 499,814 (+37.66%) | Filing History |
2023-10-23 4:20 pm Unchanged | 2023-10-20 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 10.100% | 0 (Unchanged) | Filing History |
2023-10-16 4:30 pm Purchase | 2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 2,893,615 9.990% | 1,326,368 (+84.63%) | Filing History |